NVS drugs is another one that has demonstrated very effective results and what's better is that it's only 2 sub cut injections a year....
I am sure it's too early .... but I know what I will choose between taking a daily pill or only two sub cut injections a year assuming all things being equal.....
and it's too early for Nyrada....it's just preclinical assessments...not to say there is no opportunity but again keep ur expectations fair....
It's a company with good promise but not even at a stage of clinical testing.... MC is sub 20m which is not too different to any other companies at this stage and all in their SH view has a great promise....
again it's not saying u sell.... but be patient and don't expect quick returns .... it's biotech world.... it takes years and years of waiting for have a meaningful gain unless you are very lucky (some phase 1 companies were bought outright by big Pharma giants)
NYR Price at posting:
20.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)